<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03910205</url>
  </required_header>
  <id_info>
    <org_study_id>2019-062</org_study_id>
    <nct_id>NCT03910205</nct_id>
  </id_info>
  <brief_title>Tumor Necrosis Factor-alpha and Interleukin-18 Levels in Children With Gingivitis and Type 1 Diabetes Mellitus</brief_title>
  <official_title>Gingival Crevicular Fluid Tumor Necrosis Factor-alpha and Interleukin-18 Levels in Children With Gingivitis and Type 1 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aydin Adnan Menderes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aydin Adnan Menderes University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to evaluate the levels of interleukin 18 and tumor necrosis factor-alpha
      (TNF-α) in gingival crevicular fluid (GCF) of children with type 1 diabetes mellitus and
      gingivitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eighty eight children (44 with type 1 diabetes mellitus and 44 healty; age range 7-14 years)
      will be recruited for the study. The children will be classified into four subgroups based on
      their periodontal status; 1) Children with gingivitis and diabetes mellitus (MG, n=22); 2)
      Children with type 1 diabetes mellitus with healthy periodontium (MH, n=22); 3)Healthy
      children with gingivitis (HG, n=22); 4) Healthy children with healthy periodontium (HH,
      n=22). Probing pocket depth (PPD), gingival index (GI) and plaque index (PI) will be
      recorded. Interleukin-18 and TNF-α will be analyzed in GCF and saliva samples by ELISA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 8, 2019</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Interleukin-18 level</measure>
    <time_frame>Baseline</time_frame>
    <description>IL-18</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tnf-alpha level</measure>
    <time_frame>Baseline</time_frame>
    <description>Tnf-Alpha</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">88</enrollment>
  <condition>Periodontal Diseases</condition>
  <arm_group>
    <arm_group_label>Type 1 diabetes with gingivitis</arm_group_label>
    <description>Children with type 1 diabetes mellitus and gingivitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 1 diabetes with healthy gingiva</arm_group_label>
    <description>Children with type 1 diabetes mellitus and healthy gingiva</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy patients with gingivitis</arm_group_label>
    <description>Systemically healthy patients with gingivitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy patients with healthy gingiva</arm_group_label>
    <description>Systemically healthy patients with healthy gingiva</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ELISA</intervention_name>
    <description>Enzim linked immunoabsorbant assay</description>
    <arm_group_label>Healthy patients with gingivitis</arm_group_label>
    <arm_group_label>Healthy patients with healthy gingiva</arm_group_label>
    <arm_group_label>Type 1 diabetes with gingivitis</arm_group_label>
    <arm_group_label>Type 1 diabetes with healthy gingiva</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Gingival crevicular fluid
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        88 Children with diabetes mellitus and systemically healty children with and without
        gingivitis.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children diagnosed as type 1 diabetes mellitus

          -  Age between 7 and 14 years

        Exclusion Criteria:

          -  Having another systemic problem except type 1 diabetes mellitus

          -  Children carrying orthodontic appliances
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sultan KELES, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sultan KELES</name>
      <address>
        <city>Aydin</city>
        <zip>09100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>April 9, 2019</study_first_submitted>
  <study_first_submitted_qc>April 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2019</study_first_posted>
  <last_update_submitted>November 27, 2019</last_update_submitted>
  <last_update_submitted_qc>November 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aydin Adnan Menderes University</investigator_affiliation>
    <investigator_full_name>Sultan KELES</investigator_full_name>
    <investigator_title>Assist. Prof.Dr.</investigator_title>
  </responsible_party>
  <keyword>interleukin-18</keyword>
  <keyword>gingival crevicular fluid</keyword>
  <keyword>tumor necrosis factor alpha</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Gingivitis</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

